Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Lipper's annual review of funds finds argument for performance fees on absolute return funds doubtful

Wednesday, March 27, 2013

Beverly Chandler, Opalesque London: Lipper’s Matthew Lemieux and Ed Moisson have published the annual review of the European fund industry, finding that sales across Europe totalled €230.4bn ($295bn) for 'long-term’ funds in 2012, the fifth best year for the industry over the last decade (behind 2005-06 and 2009-10). However, the firm writes, redemptions from money market funds totalled -€44.5bn ($56bn) over the year, and when these withdrawals are included the industry’s sales shrink to €185.9bn ($237bn) - only the seventh best total over the past 10 years.

Unsurprisingly the year’s sales were dominated by bond funds with inflows of €225.2bn ($289bn). High Yield bonds and Emerging Market debt funds together accounted for 40% of the net flows into the broader asset class.

Three groups attracted inflows into long-term funds of more than €10bn ($12bn): PIMCO, AXA and BlackRock.

Funds described by Lipper as asset allocation products are funds where the individual managers are able to invest across the spectrum as opportunities arise, often (but not always) with an absolute return targeted as part of an investment objective. Here Lipper finds that interest in such funds has been strongest in the UK over the past year, "but it is interesting to note that 115 asset allocation funds being sold cross-border were launched over the past year, with a further 51 launches of such products speci......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und